Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-101
Closed -$7.6K 705
2026
Q1
$7.6K Buy
+101
New +$7.2K ﹤0.01% 385
2024
Q4
Sell
-44,038
Closed -$2.12M 649
2024
Q3
$2.12M Sell
44,038
-15,614
-26% -$753K 0.04% 207
2024
Q2
$3.04M Sell
59,652
-1,797
-3% -$98.4K 0.06% 161
2024
Q1
$3.34M Buy
61,449
+37,446
+156% +$1.95M 0.06% 178
2023
Q4
$1.36M Buy
24,003
+6,453
+37% +$365K 0.02% 301
2023
Q3
$1.09M Sell
17,550
-6,791
-28% -$430K 0.02% 331
2023
Q2
$1.44M Sell
24,341
-7,962
-25% -$507K 0.03% 250
2023
Q1
$2.38M Sell
32,303
-18,126
-36% -$1.4M 0.05% 188
2022
Q4
$3.68M Sell
50,429
-1,138
-2% -$89.9K 0.1% 141
2022
Q3
$4.32M Buy
51,567
+46,720
+964% +$4.02M 0.13% 126
2022
Q2
$385K Buy
+4,847
New +$471K 0.01% 342

Other funds holding NTR

Ossiam's NTR Position: Q2 2026 in Review

Ossiam sold out of Nutrien (NTR) in Q2 2026, closing a stake of 101 shares — an estimated $7.6K sold.

Ossiam first reported a position in NTR in Q2 2022 and held it in 11 quarters. The position peaked at $4.32M in Q3 2022. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Ossiam reported no remaining Nutrien position as of Q2 2026 after selling out during the quarter.
  • Ossiam sold 101 Nutrien shares in Q2 2026, an estimated $7.6K.
  • Ossiam first reported a position in Nutrien in Q2 2022 and held it in 11 quarters.
  • Ossiam's Nutrien position peaked at $4.32M in Q3 2022.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.